Vertigo, a subjective sensation of movement, is a common clinical complaint encountered by healthcare professionals. It is often challenging to diagnose and manage due to its multifactorial etiology. This article aims to provide a comprehensive clinical approach to unraveling vertigo.
Vertigo is typically a symptom of an underlying condition, rather than a disease itself. It is frequently associated with disorders of the inner ear or brain. The two primary types are peripheral vertigo, originating from the inner ear, and central vertigo, arising from the brain or brainstem. Differentiating between these types is crucial for effective management.
The evaluation of a patient with vertigo begins with a detailed history and physical examination. The history should focus on the onset, duration, frequency, and associated symptoms. Physical examination, including a neurological exam and vestibular testing, can provide valuable clues to the underlying cause.
Diagnostic tools for vertigo include audiometric tests, vestibular function tests, and imaging studies. Audiometric tests assess hearing loss, which often accompanies vertigo. Vestibular function tests, such as the Dix-Hallpike maneuver, can help identify benign paroxysmal positional vertigo (BPPV). Neuroimaging is particularly useful in cases of suspected central vertigo.
Management of vertigo is tailored to the underlying cause. BPPV, the most common cause of vertigo, is usually managed with repositioning maneuvers. Vestibular suppressants can provide symptomatic relief but should be used judiciously due to potential side effects. In cases of central vertigo, addressing the underlying neurological condition is paramount.
Vertigo is a complex symptom with a myriad of potential causes. A systematic and comprehensive approach, combining a detailed history, thorough examination, and judicious use of diagnostic tools, can help healthcare professionals effectively diagnose and manage this challenging condition.
1.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
2.
Bayer is transforming pharmaceutical research into women's health
3.
Biomarker panel offers hope for early pancreatic cancer detection
4.
A small rise in cancer was observed following the 1986 Chernobyl accident.
5.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
1.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
2.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
3.
Immune Microenvironment Biomarkers for Early Tumor Evolution
4.
Transformative Methods in Oncology and Quality Improvement
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation